It has been reported that an AChE inhibitor reduces mitochondrial dysfunction and mitochondrial dynamic imbalance in several heart diseases including cardiac I/R injury, DIC, and high-fat diet-induced cardiomyopathy (Khuanjing et al. 2020b, 2021a; Lu et al. 2018). The gene discussed is ACHE; the disease is cardiomyopathy.